Literature DB >> 21527559

Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth.

Ugur Eskiocak1, Sang Bum Kim, Peter Ly, Andres I Roig, Sebastian Biglione, Kakajan Komurov, Crystal Cornelius, Woodring E Wright, Michael A White, Jerry W Shay.   

Abstract

Landmark cancer genome resequencing efforts are leading to the identification of mutated genes in many types of cancer. The extreme diversity of mutations being detected presents significant challenges to subdivide causal from coincidental mutations to elucidate how disrupted regulatory networks drive cancer processes. Given that a common early perturbation in solid tumor initiation is bypass of matrix-dependent proliferation restraints, we sought to functionally interrogate colorectal cancer candidate genes (CAN-genes) to identify driver tumor suppressors. We have employed an isogenic human colonic epithelial cell (HCEC) model to identify suppressors of anchorage-independent growth by conducting a soft agar-based short hairpin RNA (shRNA) screen within the cohort of CAN-genes. Remarkably, depletion of 65 of the 151 CAN-genes tested collaborated with ectopic expression of K-RAS(V12) and/or TP53 knockdown to promote anchorage-independent proliferation of HCECs. In contrast, only 5 of 362 random shRNAs (1.4%) enhanced soft agar growth. We have identified additional members of an extensive gene network specifying matrix-dependent proliferation, by constructing an interaction map of these confirmed progression suppressors with approximately 700 mutated genes that were excluded from CAN-genes, and experimentally verifying soft agar growth enhancement in response to depletion of a subset of these genes. Collectively, this study revealed a profound diversity of nodes within a fundamental tumor suppressor network that are susceptible to perturbation leading to enhanced cell-autonomous anchorage-independent proliferative fitness. Tumor suppressor network fragility as a paradigm within this and other regulatory systems perturbed in cancer could, in large part, account for the heterogeneity of somatic mutations detected in tumors. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527559      PMCID: PMC3326261          DOI: 10.1158/0008-5472.CAN-11-0794

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  A genetic screen for candidate tumor suppressors identifies REST.

Authors:  Thomas F Westbrook; Eric S Martin; Michael R Schlabach; Yumei Leng; Anthony C Liang; Bin Feng; Jean J Zhao; Thomas M Roberts; Gail Mandel; Gregory J Hannon; Ronald A Depinho; Lynda Chin; Stephen J Elledge
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

2.  A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity.

Authors:  Ingrid G M Kolfschoten; Bart van Leeuwen; Katrien Berns; Jasper Mullenders; Roderick L Beijersbergen; Rene Bernards; P Mathijs Voorhoeve; Reuven Agami
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

3.  Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma.

Authors:  Mohammad H Soltani; Rita Pichardo; Ziqui Song; Namrata Sangha; Fabian Camacho; Kapaettu Satyamoorthy; Omar P Sangueza; Vijayasaradhi Setaluri
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

4.  Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

Authors:  S Ries; C Biederer; D Woods; O Shifman; S Shirasawa; T Sasazuki; M McMahon; M Oren; F McCormick
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

5.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

6.  Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

Authors:  Mitsuo Sato; Melville B Vaughan; Luc Girard; Michael Peyton; Woochang Lee; David S Shames; Ruben D Ramirez; Noriaki Sunaga; Adi F Gazdar; Jerry W Shay; John D Minna
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

Review 7.  The functional contrariety of JNK.

Authors:  Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2007-08       Impact factor: 4.784

8.  The genomic landscapes of human breast and colorectal cancers.

Authors:  Laura D Wood; D Williams Parsons; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Steve Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James K V Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
Journal:  Science       Date:  2007-10-11       Impact factor: 47.728

9.  Chemical genetic analysis of the time course of signal transduction by JNK.

Authors:  Juan-Jose Ventura; Anette Hübner; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

10.  Identifying cancer driver genes in tumor genome sequencing studies.

Authors:  Ahrim Youn; Richard Simon
Journal:  Bioinformatics       Date:  2010-12-17       Impact factor: 6.937

View more
  15 in total

1.  RNAi screening of the human colorectal cancer genome identifies multifunctional tumor suppressors regulating epithelial cell invasion.

Authors:  Peter Ly; Ugur Eskiocak; Chelsea R Parker; Kenneth J Harris; Woodring E Wright; Jerry W Shay
Journal:  Cell Res       Date:  2012-10-09       Impact factor: 25.617

2.  Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer.

Authors:  Lu Zhang; Panayotis C Theodoropoulos; Ugur Eskiocak; Wentian Wang; Young-Ah Moon; Bruce Posner; Noelle S Williams; Woodring E Wright; Sang Bum Kim; Deepak Nijhawan; Jef K De Brabander; Jerry W Shay
Journal:  Sci Transl Med       Date:  2016-10-19       Impact factor: 17.956

3.  Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.

Authors:  Zhiguo Chen; Chung-Ping Liao; Kun Chen; Jonathan M Cooper; Amish J Patel; Juan Mo; Yong Wang; Lu Q Le
Journal:  Clin Cancer Res       Date:  2019-02-22       Impact factor: 12.531

4.  Identification of novel driver tumor suppressors through functional interrogation of putative passenger mutations in colorectal cancer.

Authors:  Lu Zhang; Kakajan Komurov; Woodring E Wright; Jerry W Shay
Journal:  Int J Cancer       Date:  2012-07-21       Impact factor: 7.396

5.  RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression.

Authors:  Rosalyn R Ram; Saurabh Mendiratta; Brian O Bodemann; Michael J Torres; Ugur Eskiocak; Michael A White
Journal:  Mol Cell Biol       Date:  2014-04-14       Impact factor: 4.272

6.  RET is a potential tumor suppressor gene in colorectal cancer.

Authors:  Y Luo; K D Tsuchiya; D Il Park; R Fausel; S Kanngurn; P Welcsh; S Dzieciatkowski; J Wang; W M Grady
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

7.  Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.

Authors:  Snehangshu Kundu; Muhammad Akhtar Ali; Niklas Handin; Narendra Padhan; Jimmy Larsson; Maria Karoutsou; Kenneth Ban; Jacek R Wiśniewski; Per Artursson; Liqun He; Mats Hellström; Tobias Sjöblom
Journal:  Genome Med       Date:  2018-01-04       Impact factor: 11.117

8.  Integrative genomic and functional profiling of the pancreatic cancer genome.

Authors:  A Hunter Shain; Keyan Salari; Craig P Giacomini; Jonathan R Pollack
Journal:  BMC Genomics       Date:  2013-09-16       Impact factor: 3.969

9.  The estrogen-related receptor α inverse agonist XCT 790 is a nanomolar mitochondrial uncoupler.

Authors:  Banu Eskiocak; Aktar Ali; Michael A White
Journal:  Biochemistry       Date:  2014-07-14       Impact factor: 3.162

10.  Genotoxicity of Cytolethal Distending Toxin (CDT) on Isogenic Human Colorectal Cell Lines: Potential Promoting Effects for Colorectal Carcinogenesis.

Authors:  Vanessa Graillot; Inge Dormoy; Jacques Dupuy; Jerry W Shay; Laurence Huc; Gladys Mirey; Julien Vignard
Journal:  Front Cell Infect Microbiol       Date:  2016-03-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.